Mayumi Sako

发表

Combination therapy with or without warfarin and dipyridamole for severe childhood IgA nephropathy: an RCT

K. Nakanishi, N. Yoshikawa, K. Nozu, 2018, Pediatric Nephrology.

Spontaneous remission in children with IgA nephropathy

K. Nakanishi, N. Yoshikawa, K. Nozu, 2012, Pediatric Nephrology.

A prospective study of allogeneic hematopoietic stem cell transplantation with post-transplantation cyclophosphamide and anti-thymoglobulin from HLA-mismatched related donors for non-malignant diseases.

H. Kanegane, E. Inoue, Y. Yuza, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Guidelines for the management and investigation of hemolytic uremic syndrome

M. Ohnishi, J. Tang, M. Mizuguchi, 2014, Clinical and Experimental Nephrology.

Long-term outcome of childhood-onset complicated nephrotic syndrome after a multicenter, double-blind, randomized, placebo-controlled trial of rituximab

K. Nakanishi, S. Ito, T. Morimoto, 2017, Pediatric Nephrology.

Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial

R. Mori, Y. Ohashi, K. Nakanishi, 2014, The Lancet.

Increased chymase-positive mast cells in children with crescentic glomerulonephritis

K. Nakanishi, N. Yoshikawa, K. Nozu, 2009, Pediatric Nephrology.

K. Nakanishi, N. Yoshikawa, D. Tokuhara, 2023, Pediatric nephrology.

Clinicopathological significance of glomerular capillary IgA deposition in childhood IgA nephropathy

K. Nakanishi, N. Yoshikawa, K. Nozu, 2020, Pediatric Nephrology.

Crescentic IgA nephropathy in children

K. Nakanishi, N. Yoshikawa, K. Nozu, 2020, Pediatric Nephrology.

IgA nephropathy with presentation of nephrotic syndrome at onset in children

K. Nakanishi, N. Yoshikawa, K. Nozu, 2017, Pediatric Nephrology.

Long-term outcome of childhood IgA nephropathy with minimal proteinuria

K. Nakanishi, N. Yoshikawa, K. Nozu, 2015, Pediatric Nephrology.

Validity of the Oxford classification of IgA nephropathy in children

K. Nakanishi, N. Yoshikawa, K. Iijima, 2012, Pediatric Nephrology.

Analysis of NPHS1, NPHS2, ACTN4, and WT1 in Japanese patients with congenital nephrotic syndrome.

K. Nakanishi, Yasuhiko Takahashi, N. Yoshikawa, 2005, Kidney international.

Needs Assessment for Supports to Promote Pediatric Clinical Research Using an Online Survey of the Japanese Children’s Hospitals Association

Chie Nagata, Osamu Nomura, A. Ishiguro, 2020, JMA journal.

Clinical characteristics at the renal replacement therapy initiation of Japanese pediatric patients: a nationwide cross-sectional study

E. Inoue, M. Hattori, Shori Takahashi, 2019, Clinical and Experimental Nephrology.

Clinical practice guideline for pediatric idiopathic nephrotic syndrome 2013: general therapy

K. Nakanishi, Takuhito Nagai, K. Iijima, 2015, Clinical and Experimental Nephrology.

Clinical practice guideline for pediatric idiopathic nephrotic syndrome 2013: medical therapy

K. Nakanishi, Takuhito Nagai, K. Iijima, 2014, Clinical and Experimental Nephrology.

Transition of adolescent and young adult patients with childhood-onset chronic kidney disease from pediatric to adult renal services: a nationwide survey in Japan

Y. Kawasaki, M. Hattori, S. Maruyama, 2016, Clinical and Experimental Nephrology.

End-stage renal disease in Japanese children: a nationwide survey during 2006–2011

M. Hattori, T. Kaneko, T. Igarashi, 2015, Clinical and Experimental Nephrology.

A multicenter randomized trial indicates initial prednisolone treatment for childhood nephrotic syndrome for two months is not inferior to six-month treatment

E. Ota, R. Mori, S. Ito, 2014, Kidney international.

Epithelial-to-mesenchymal transition in cyst lining epithelial cells in an orthologous PCK rat model of autosomal-recessive polycystic kidney disease.

S. Nagao, K. Nakanishi, K. Nishii, 2011, American journal of physiology. Renal physiology.

Pilot study to estimate the safety and effectiveness of hydroxyurea and methotrexate recurrent langerhans cell histiocytosis (LCH-HU-pilot)

K. Sakamoto, Y. Shioda, T. Takimoto, 2022, Medicine.

Study protocol: high-dose mizoribine with prednisolone therapy in short-term relapsing steroid-sensitive nephrotic syndrome to prevent frequent relapse (JSKDC05 trial)

K. Nakanishi, S. Ito, N. Yoshikawa, 2018, BMC Nephrology.

Study protocol: multicenter double-blind, randomized, placebo-controlled trial of rituximab for the treatment of childhood-onset early-stage uncomplicated frequently relapsing or steroid-dependent nephrotic syndrome (JSKDC10 trial)

K. Nakanishi, Hidefumi Nakamura, T. Omori, 2019, BMC Nephrology.

Rituximab for nephrotic syndrome in children

K. Nozu, K. Iijima, M. Sako, 2016, Clinical and Experimental Nephrology.

Single dose of rituximab for refractory steroid-dependent nephrotic syndrome in children

S. Ito, K. Nozu, K. Iijima, 2009, Pediatric Nephrology.